Single-blind randomized clinical trial in premature infants with Respiratory Distress Syndrome (RDS) eligible for treatment with exogenous surfactant identified early by lung ultrasonography.
- Conditions
- Premature infants with Respiratory Distress Syndrome (RDS)Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 30
Premature newborns of both sexes, between 24 and 32 weeks and/or = 1500 grams at birth, who do not meet any of the exclusion criteria, will be included.
Lack of parental informed consent., Patients presenting with any of the following conditions: • Chromosomal abnormalities or complex congenital malformations., Patients presenting with any of the following conditions: Congenital lung diseases., Patients presenting with any of the following conditions: Severe sepsis or septic shock., Patients presenting with any of the following conditions: Meconium aspiration syndrome., Patients presenting with any of the following conditions: Administration of surfactant in the delivery room.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.